Počet záznamov: 1
fenretinid
SYS d017313 LBL 00000nz--a2200000o--4500 005 20250606214915.3 008 920519|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D02.455.326.271.665.202.495.270 065 $a D02.455.426.392.368.367.379.249.700.270 065 $a D02.455.849.131.495.270 065 $a D23.767.261.700.270 066 $a 01 $c 03 150 $a fenretinid $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a 4-HPR $2 eng 450 $w v $a 4-HPR $2 slo 550 $7 sllk_us_auth*d000970 $Y Antineoplastic Agents $w P $a antineoplastiká 550 $7 sllk_us_auth*d016588 $Y Anticarcinogenic Agents $w P $a antikarcinogény 665 $a 93; was FENRETINIDE (NM) 1979-92 $2 eng 665 $a Tretinoin/analogs & derivatives (1979-1992) $2 eng 680 9-
$i A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent. $2 eng 750 -2
$a Fenretinide $2 eng 980 $x M
Počet záznamov: 1